KSKazuko Shiozawa

Kazuko Shiozawa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kazuko Shiozawa has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Akira Hashiramoto

    Kobe University FHS School of Medicine, Kobe University Graduate School of Medicine, and Kobe University Hospital, Kobe, Japan

    1 shared publication
  • Kayo Osawa

    Kobe University FHS School of Medicine, and Kobe University Graduate School of Medicine, Kobe, Japan

    1 shared publication
  • Keizo Sato

    Kobe Rosai Hospital, Kobe, Japan

    1 shared publication
  • Koichiro Komai

    Kobe University FHS School of Medicine, and Kobe University Graduate School of Medicine, Kobe, Japan

    1 shared publication
  • Mariko Taniguchi

    Kobe University FHS School of Medicine, and Kobe University Graduate School of Medicine, Kobe, Japan

    1 shared publication
  • Masahiko Shiraishi

    National Cancer Center Research Institute, Tokyo, Japan

    1 shared publication

Latest Publications

  • Open Access

    Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells

    by Nozomi Takami, Kayo Osawa, Yasushi Miura, Koichiro Komai, Mariko Taniguchi, Masahiko Shiraishi, Keizo Sato, Tetsuhiro Iguchi, Kazuko Shiozawa, Akira Hashiramoto, et al.

    Objective: To examine the promoter activity and protein expression of the death receptor 3 gene DR3, a member of the apoptosis‐inducing Fas gene family, with particular reference to the methylation status of its promoter region in rheumatoid arthritis (RA).Methods: Genomic DNA was prepared from peripheral blood mononuclear cells obtained from healthy individuals and from patients with RA and synovial cells obtained from patients with RA and osteoarthritis. The methylation status of the DR3 promoter was analyzed by bisulfite genomic sequencing and methylation‐specific polymerase chain reaction techniques. Gene promoter activity and protein expression were examined using the luciferase reporter and Western blotting techniques.Results: The promoter region of the DR3 gene contained many CpG motifs, including one CpG island that was specifically hypermethylated in synovial cells from patients with RA. Promoter assays showed that the promoter CpG island was essential for the transactivation of the DR3 gene and that forced hypermethylation of the CpG island with the bacterial methylase Sss I in vitro resulted in inhibition of the DR3 gene expression. Furthermore, the expression of DR‐3 protein was down‐modulated in association with methylation of the promoter CpG island in RA synovial cells.Conclusion: The CpG island in the DR3 gene promoter was specifically methylated to down‐modulate the expression of DR‐3 protein in rheumatoid synovial cells, which may provide resistance to apoptosis in RA synovial cells.